Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 02:00:00 02/07/2024 am IST 		5-day change 1st Jan Change
1.93 USD +2.39% Intraday chart for Genprex, Inc. -4.46% -79.02%
15/05 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
14/05 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI

Chart calendar Genprex, Inc.

fa5d60e.hngLz44YoZ2ZaN2pUp_aDjZcXzi7VaFdU6Nu3MF77jA.4gh6quhXwNf9X7nfIsiXQmkDGFTYI5AwA5Ioj_geiwbtNyaDuXbj8NwemA~064c96228d78178fe6a9351f034a504d

Upcoming events on Genprex, Inc.

No events available

Past events on Genprex, Inc.

18/06/2024 08:00 pm Annual General Meeting
04/06/2024 02:30 am Bio International Convention
09/05/2024 12:45 am Sidoti Virtual Micro-Cap Conference
07/05/2024 American Society of Gene & Cell Therapy Meeting
09/04/2024 02:00 am American Association for Cancer Research Meeting - Abstrac No:3158
08/04/2024 09:30 pm American Association for Cancer Research Meeting - Abstract No:1420
08/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract No:351
27/02/2024 12:00 am BIO CEO & Investor Conference
14/12/2023 08:30 pm Extraordinary Shareholders Meeting
07/11/2023 09:15 pm Bio-Europe Conference
27/10/2023 10:00 pm Investor Meeting - Key Opinion Leader
12/10/2023 10:00 pm AACR-NCI-EORTC International Conference - Poster No:AO66
12/10/2023 10:00 pm AACR-NCI-EORTC International Conference - Poster No:AO65
14/09/2023 12:30 am H.C. Wainwright Global Investment Conference
27/06/2023 07:30 pm Annual General Meeting
02/06/2023 American Society of Clinical Oncology Conference
23/05/2023 A.G.P Virtual Healthcare Conference
16/05/2023 American Society of Gene Cell Therapy Meeting
11/05/2023 09:45 pm Sidoti Micro-Cap Virtual Conference
18/04/2023 11:00 pm American Association for Cancer Research Meeting - Abstract No: 5120

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-18,0
-16,3
-10.19%		-19,6
-18,5
-5.67%		-23,8
-24,2
1.69%		-31,1
-33,1
6.11%
-24,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		-19,6
-17,9
-9.49%		0,00
0,00
- 		0,00
0,00
-
-24,0

Net income
Million USD		Released
Forecast
Spread 		-10,7


-17,9
-16,3
-10.08%		-19,6
-18,5
-5.86%		-23,7
-24,2
2.01%		-30,9
-32,9
6.12%
-24,0

EPS
USD		Released
Forecast
Spread 		-26,4


-20,4
-15,2
-34.21%		-16,8
-15,2
-10.53%		0,00
0,00
- 		0,00
0,00
-
-5,70

Announcement Date30/03/2026/03/2130/03/2231/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
-


0,00
0,00
-


0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-5,72
-4,50
-27.19%		-5,18
-6,00
13.75%		-6,11
-6,75
9.47%		-6,82
-7,25
5.91%		-5,99
-8,00
25.2%		-6,00
-6,05
0.93%
-6,00


-6,00


-6,00







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,72
-4,50
-27.19%











-5,97
-6,05
1.39%
-6,00


-6,00


-6,00







Net income
Million USD		Released
Forecast
Spread 		-5,72
-4,50
-27.19%		-5,17
-6,00
13.89%		-6,08
-6,75
9.92%		-6,77
-7,25
6.71%		-5,93
-7,96
25.47%		-5,97
-6,05
1.39%
-6,00


-6,00


-6,00







EPS
USD		Released
Forecast
Spread 		-4,80
-3,60
-33.33%











-3,69
-2,54
-45.28%
-2,30


-1,13


-0,82


-0,82


-0,71

Announcement Date13/05/2212/08/2214/11/2231/03/2301/04/2415/05/24-----

Upcoming sector events for Genprex, Inc.

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Genprex, Inc.

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Calendar Genprex, Inc.